Butcher Arthur C 4

What Happened
Arthur C. Butcher, EVP & Group President, MedSurg & APAC at Boston Scientific (BSX), acquired 6,851 shares on Feb 19, 2026 at $75.76 per share for a total of $519,032. The filing reports this as an acquisition (purchase) resulting from a discretionary transaction.

Key Details

• Transaction date and price: 2026-02-19, 6,851 shares at $75.76 each (total ~$519,032).
• Transaction type/code: Acquisition via discretionary transaction (code I) under the company plan.
• Method: Purchase made pursuant to an election to rebalance holdings in the company 401(k) Retirement Savings Plan (see footnote F1).
• Shares owned after transaction: Not specified in the Form 4; footnote F2 says the balance reflects the most current 401(k) plan data.
• Filing timeliness: Form filed 2026-02-27 for a 2026-02-19 trade — more than two business days after the transaction, so the filing appears late relative to the usual 2-business-day Form 4 deadline.

Context
This was a plan-based rebalancing purchase within the company 401(k) plan rather than an open-market buy. Such retirement-plan rebalancings are common and reflect plan elections rather than a discretionary open-market investment decision, though they still increase insider ownership.